Federal Register Notice: FDA’s Advisory Committee for Reproductive Health Drugs will meet 6/18, from 8 a.m. to 4:30 p.m. at the Hilton Washington DC North/Gaithersburg, The Ballrooms, 620 Perry Pkwy., Gaithersburg, MD. Contact Kalyani Bhatt, (301) 827-7001. On 6/18 the committee will discuss a Boehringer Ingelheim Pharmaceuticals NDA for flibanserin 100 mg tablets for treating hypoactive sexual desire disorder in premenopausal women. To view this notice, click here.